RTW Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

RTW Investments’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07B	Hold	1,993,687	–	–	9.14%	1
2026 Q1	$1.04B	Hold	1,993,687	–	–	10.38%	1
2025 Q4	$1.16B	Hold	1,993,687	–	–	11.63%	1
2025 Q3	$914M	Hold	1,993,687	–	–	11.27%	1
2025 Q2	$603M	Hold	1,993,687	–	–	8.59%	1
2025 Q1	$660M	Hold	1,993,687	–	–	10.1%	1
2024 Q4	$615M	Hold	1,993,687	–	–	9.3%	1
2024 Q3	$423M	Buy	1,993,687 +77,825	+4%	+$19.9M	6.12%	1
2024 Q2	$537M	Buy	1,915,862 +1,518,815	+383%	+$362M	8.31%	1
2024 Q1	$106M	Sell	397,047 -418,144	-51%	-$98.5M	1.57%	24
2023 Q4	$189M	Buy	815,191 +505,706	+163%	+$88.5M	2.95%	12
2023 Q3	$45.2M	Buy	309,485 +87,923	+40%	+$16.5M	0.95%	29
2023 Q2	$51.2M	Buy	+221,562	New	+$60M	0.97%	26

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RTW Investments's MDGL Position: Q2 2026 in Review

RTW Investments held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 1,993,687 shares worth $1.07B. The position accounts for 9.14% of the portfolio, ranked #1.

RTW Investments first reported a position in MDGL in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.16B in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

RTW Investments held 1,993,687 shares of Madrigal Pharmaceuticals worth $1.07B as of Q2 2026.
RTW Investments left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
Madrigal Pharmaceuticals made up 9.14% of RTW Investments's portfolio in Q2 2026, its #1 holding.
RTW Investments first reported a position in Madrigal Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
RTW Investments's Madrigal Pharmaceuticals position peaked at $1.16B in Q4 2025.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.